Transplantation

Latest News

Vaccinated Kidney Transplant Recipients Vulnerable to SARS-CoV-2 Variants

After two-dose vaccination, only 64 and 67 percent of kidney transplant recipients showed neutralization against B.1.351 (β) and B.1.617.2 (δ)

Short-Term Outcomes of Heart Transplant From Donor After Circulatory Death

Given the promising early results of donation after circulatory death for heart transplants in Europe and Australia, researchers investigated outcomes in the US.

Diagnostic Accuracy of Cardiac MRI for Evaluating Transplant Rejection

Researchers conducted a meta-analysis to determine the diagnostic performance of multiple methods of cardiac magnetic resonance imaging used to identify acute transplant rejection.

Liver Transplants for Alcoholic Hepatitis Up During COVID-19 Pandemic

Disproportionate increase in waiting-list registrations, liver transplants for alcoholic hepatitis associated with increasing alcohol sales.

Model Predicts Risk for Patients on Waitlist for Cardiac Surgery

Clinical risk model predicts risk for composite outcome of death and unplanned cardiac hospitalization for patients on cardiac surgery waitlist.

Monoclonal Antibodies for COVID-19 Effective for Transplant Patients

Favorable outcomes, minimal adverse effects seen in solid organ transplant recipients who received monoclonal antibody therapy for COVID-19.

Heart Transplant Outcomes Comparable in Advanced Age

Survival up to five years after a heart transplant is similar for patients aged 70 years and older and those younger than 70 years.

Assessment of Cardiac Risk Stratification in Liver Transplantation

Adult patients anticipating liver transplantation could benefit from the selective use of three-tiered cardiac risk stratification protocol.

Mortality Risk Higher for Young Black Heart Recipients

Young Black heart recipients have an increased risk for mortality in the first year after transplant.

Blood Biomarker May Detect Acute Heart Transplant Rejection

Blood test measuring percent donor-derived cell-free DNA could eliminate much of the need for endomyocardial biopsy.